Metascreen™, a comprehensive metabolic screening test currently designed for newborn babies, is the first of Cordlife Group’s new product and service offerings in diagnostics, as the Group transforms into a consumer healthcare company catering to the mother and child segment.
Compared to other similar screening services that require blood for testing, Metascreen™ is a non-invasive and painless test that can screen for more than 100 inborn errors of metabolism using urine samples of newborns. With the early critical information on the health status of their child provided by Metascreen™, parents can now better safeguard their child’s health.
The metabolic screening tests offered under the brand, Metascreen™, will be conducted and analysed by Hong Kong Screening Centre, a company committed to providing early and accurate detection of metabolic disorders. Hong Kong Screening Centre, a subsidiary of Cordlife, has a quality management system in place to ensure maximum accuracy of screening results.